A novel anti-peroxiredoxin autoantibody in patients with Kawasaki disease

Microbiology and Immunology

Volumn 56, Issue 1, 2012, Pages 56-61

  Fujieda, Mikiya ^a   Karasawa, Rie ^b   Takasugi, Hisashi ^a   Yamamoto, Masaki ^a   Kataoka, Koichi ^c,d   Yudoh, Kazuo ^b   Kato, Tomohiro ^b   Ozaki, Shoichi ^b   Wakiguchi, Hiroshi ^a  

^a KOCHI UNIVERSITY   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Kochi Health Sciences Center   (Japan)

^d Jichi Children's Medical Center Tochigi   (Japan)

Author keywords

8 isoprostaglandin F2 ; Kawasaki disease; Oxidative stress; Peroxiredoxin

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ACETYLSALICYLIC ACID; AUTOANTIBODY; C REACTIVE PROTEIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; PEROXIREDOXIN 1; PEROXIREDOXIN 1 AUTOANTIBODY; PEROXIREDOXIN 2; PEROXIREDOXIN 2 AUTOANTIBODY; PEROXIREDOXIN 4; PEROXIREDOXIN 4 AUTOANTIBODY; PEROXIREDOXIN AUTOANTIBODY; UNCLASSIFIED DRUG;

AGE; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTERY LESION; ARTICLE; BACTERIAL MENINGITIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; CORONARY ARTERY; CORONARY ARTERY DILATATION; CORONARY ARTERY LESION; DISEASE MARKER; DRUG MEGADOSE; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; HUMAN; LEUKOCYTE COUNT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEUTROPHIL COUNT; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; SEPTICEMIA; URINALYSIS; WESTERN BLOTTING;

ANTIOXIDANTS; AUTOANTIBODIES; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GAMMA-GLOBULINS; HUMANS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; OXIDATIVE STRESS; PEROXIREDOXINS; PREVALENCE; PROSTAGLANDINS; SEVERITY OF ILLNESS INDEX;

EID: 84856857940     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2011.00393.x     Document Type: Article

References (21)

1. Kaneko K., Savage C.O., Pottinger B.E., Shah V., Pearson J.D., Dillon M.J. (1994) Anti-endothelial cell antibodies can be cytotoxic to endothelial cells without cytokine pre-stimulation and correlate with ELISA antibody measurement in Kawasaki disease. Clin Exp Immunol 98: 264-9.
2. Fujieda M., Oishi N., Kurashige T. (1997) Antibodies to endothelial cells in Kawasaki disease lyse endothelial cells without cytokine pretreatment. Clin Exp Immunol 107: 120-6.
3. Grunebaum E., Blank M., Cohen S., Afek A., Kopolovic J., Meroni P.L., Youinou P., Shoenfeld Y. (2002) The role of anti-endothelial cell antibodies in Kawasaki disease- in vitro and in vivo studies. Clin Exp Immunol 130: 233-40.
4. Tsujimoto H., Takashita S., Nakatani K., Kawamura Y., Tokutomi T., Sekine I. (2001) Delayed apoptosis of circulating neutrophils in Kawasaki disease. Clin Exp Immunol 126: 355-64.
5. Kim HY., Lee H.G., Kim D.S. (2000) Apoptosis of peripheral blood mononuclear cells in Kawasaki disease. J Rheumatol 27: 801-6.
6. Karasawa R., Ozaki S., Nishioka K., Kato T. (2005) Autoantibodies to peroxiredoxin I and IV in patients with systemic autoimmune diseases. Microbiol Immunol 49: 57-65.
7. Karasawa R., Kurokawa M.S., Yudoh K., Masuko K., Ozaki S., Kato T. (2010) Peroxiredoxin 2 is a novel autoantigen for anti-endothelial cell antibodies in systemic vasculitis. Clin Exp Immunol 161: 459-70.
8. Takatsuki S., Ito Y., Takeuchi D., Hoshida H., Nakayama T., Matsuura H., Saji T. (2009) IVIG reduced vascular oxidative stress in patients with Kawasaki disease. Circ J 73: 1315-8.
9. Wood Z.A., Schroder E, Harris J.R., Poole L.B. (2003) Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 28: 32-40.
10. Xiang Y., Sekine T., Nakamura H., Imajoh-Ohmi S., Fukuda H., Nishioka K., Kato T. (2004) Proteomic surveillance of autoimmunity in osteoarthritis: identification of triosephosphate isomerase as an autoantigen in patients with osteoarthritis. Arthritis Rheum 50: 1151-521.
11. Mitsumoto A., Takanesawa Y., Okawa K., Iwamatsu A., Nakagawa Y. (2001) Variants of peroxiredoxins expression in response to hydroperoxide stress. Free Radic Biol Med 30: 625-35.
12. Bryk R., Griffin P., Nathan C. (2000) Peroxynitrite reductase activity of bacterial peroxiredoxins. Nature 407: 211-5.
13. Peshenko I.V., Shichi H. (2001) Oxidation of active center cysteine of bovine 1-CYS peroxiredoxin to the cysteine sulfenic acid form by peroxide and peroxynitrite. Free Radic Biol Med 31: 292-303.
14. Hofmann B., Hecht H-J., Flohe L. (2002) Peroxiredoxins. Biol Chem 383: 347-64.
15. Mayr M., Chung Y.L., Mayr U., Yin X., Ly L., Troy H., Fredericks S., Hu Y., Griffiths J.R., Xu Q. (2005) Proteomic and metabolomic analyses of atherosclerotic vessels from apolipoprotein E-deficient mice reveal alterations in inflammation, oxidative stress, and energy metabolism. Arterioscler Thromb Vasc Biol 25: 2135-42.
16. Cohen Tervaert J.W. (2009) Translational mini-review series on immunology of vascular disease: accelerated atherosclerosis in vasculitis. Clin Exp Immunol 156: 377-85.
17. 2-generating activity in human coronary artery endothelial cells upon induction with tumor necrosis factor-α. Int Immunopharmacol 8: 1377-85.
18. Suzuki H., Noda E., Miyamura M., Takeuchi T., Uemura S., Koike M. (2001) Serum levels of neutrophil activation cytokines in Kawasaki disease. Pediatr Int 43: 115-9.
19. Springer B., Master S., Sander P., Zahrt T., McFalone M., Song J., Papavinasasundaram K.G., Colston M.J., Boettger E., Deretic V. (2001) Silencing of oxidative stress response in Mycobacterium tuberculosis: expression patterns of ahpC in virulent and avirulent strains and effect of ahpC inactivation. Infect Immunol 69: 5967-73.
20. Nakamura T., Yamamuta J., Sato H., Kakinuma H., Takahashi H. (2007) Vasculitis induced by immunization with Bacillus Calmette-Guérin followed by atypical mycobacterium antigen: a new mouse model for Kawasaki disease. Immunol Med Microbiol 49: 391-7.
21. Rhoe S.G., Chae H.Z., Kim K. (2005) Peroxiredoxins: A historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radical Biol & Medicine 38: 1543-52.